IgG4-related sclerosing cholangitis may be a risk factor for cancer,Journal of Hepato-Biliary-Pancreatic Sciences

当前位置： X-MOL 学术 › J. Hepato Biliary Pancreat. Sci. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

IgG4-related sclerosing cholangitis may be a risk factor for cancer
Journal of Hepato-Biliary-Pancreatic Sciences ( IF 3 ) Pub Date : 2021-04-30 , DOI: 10.1002/jhbp.957
Yusuke Kurita ₁ , Yuji Fujita ₂ , Yusuke Sekino ₃ , Seitaro Watanabe ₄ , Akito Iwasaki ₅ , Koichi Kagawa ₆ , Emiko Tanida ₇ , Shin Yagi ₁ , Sho Hasegawa ₁ , Takamitsu Sato ₁ , Kunihiro Hosono ₁ , Shingo Kato ₁ , Noritoshi Kobayashi ₈ , Yasushi Ichikawa ₈ , Itaru Endo ₉ , Atsushi Nakajima ₁ , Kensuke Kubota ₁

Affiliation

The relationship between autoimmune pancreatitis (AIP) and malignancy has been reported. However, the potential risk for cancer in patients with immunoglobulin 4 (IgG4)-related sclerosing cholangitis (IgG4-SC) is unclear. The present study aimed to evaluate the incidence of cancer in IgG4-SC patients.

中文翻译：